Zavicefta ceftazidime/avibactam regulatory update

EMA’s CHMP recommended approval of Zavicefta ceftazidime/avibactam from AstraZeneca to treat adults with complicated intra-abdominal infections (cIAI);

Read the full 172 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE